Hint mode is switched on Switch off

GGX1 - Global X China Biotech Innovation ETF (USD) (US37954Y2515)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access

Choose all Reset all
ETF & Funds ceased circulation
 
(%)
US37954Y2515
GGX1 ISIN
Exchange Traded Funds (ETF)
Type of fund
Mirae Asset Global Investments
Provider
-
NAV per Share
22/09/2020
Inception Date
2 times per year
Dividend payments
CEOJLS
CFI
-
Ticker
Closed
Status
Equity
Investment category
Biotech
Sector
China
Investor locations
Solactive China Biotech Innovation Index
Benchmark
0.65 %
Total Cost Ratio
Physical
Replication method
1.41 mln USD
Fund NAV | 15/02/2024
1.41 mln USD
Share Class NAV | 15/02/2024
No
UCITS
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on
Latest data on 15/02/2024
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The Global X China Biotech Innovation ETF aims to track the performance (before fees and expenses) of the Solactive China Biotech Innovation Index, which seeks to invest in companies that are directly involved in China’s biotechnology industry.

GGX1 profile

The Global X China Biotech Innovation ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in China. The Mirae Asset Global Investments fund’s base currency is USD and the share class was registered 22.09.2020 with unique ISIN - US37954Y2515. The total expense ratio is 0.65%. The Global X China Biotech Innovation ETF (USD) pays dividends 2 time(s) per year.

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access
Registration is required to get access.